2024 ASH Review: Current Updates in Hematologic Diseases
Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients and their families. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the U.S. and around the world.
Bristol Myers Squibb
Daiichi Sankyo, Inc.
At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting-edge science and technology with a genuine interest in people, we develop high-quality, life-changing solutions for the patients of today and tomorrow. We rely on reason, ingenuity, perseverance, and empathy to make bold strides in oncology.
We commit to a culture of equity and belonging that fuels exceptional value for our patients and business and unlocks the power of our people. It is the sum of our diverse perspectives, experiences and skills that informs our collective capability.
Our success comes from experts in collaboration: our people, scientists, health care providers, advocates – and patients themselves. Building on a 120-year heritage and a culture of innovation, we’re forging better futures through medicine for people everywhere. Together, we are creating new standards of care—our contribution to the enrichment of quality of life around the world.
Please visit www.daiichisankyo.us.
Daiichi Sankyo, Inc.
Johnson & Johnson
Kite, A Gilead Company
At Kite, our singular focus is cell therapy to treat and potentially cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit.
We believe cell therapy has the ability to change the way cancer is treated. Our industry-leading cell therapy technology uses the power of a patient's own immune system to target and attack their cancer cells.
Kyowa Kirin, Inc.
Pharmacyclics, An AbbVie Company
Here at Menarini-Stemline, The goal of our dedicated team of scientists, specialists, researchers and developers is to build a leading biopharmaceutical company focused on improving the lives of cancer patients by developing and commercializing novel first-in-class therapeutics.
Sun Dermatology (the branded dermatology division of Sun Pharmaceutical Industries Inc. in the United States) is committed to expanding its dermatology portfolio to bring more treatment options and ongoing support for healthcare providers and patients. For more than 30 years, it has been dedicated to advancing the science of dermatology for a variety of conditions. Sun Pharmaceutical Industries Ltd., along with its subsidiaries, is ranked second in dermatology prescription volume within the U.S. per IQVIA.
eeds Privacy and Registration Refund Policy
eeds Accessibility Statement